HHS Moves to Challenge Ruling on Vaccine Policy Changes
The U.S. Department of Health and Human Services (HHS) is appealing a ruling that impacts vaccine policy, following a lawsuit by the American Association of Pediatrics.
Latest Health stories from Life.
The U.S. Department of Health and Human Services (HHS) is appealing a ruling that impacts vaccine policy, following a lawsuit by the American Association of Pediatrics.
During a recent session, Supreme Court justices indicated that they may not challenge the validity of skinny labeling, suggesting potential support for its continuation.
A recent FDA study of 312 infant formula brands revealed minimal levels of harmful substances, including heavy metals and pesticides.
An analysis highlights the distinct characteristics of nursing homes located in rural areas compared to their urban counterparts, based on recent data.
Recent developments in the biotech sector include a patent win for Pfizer and BridgeBio, alongside changes to FDA clinical trial data review and Rocket's sale of its priority review voucher.
The FDA is taking steps to accelerate clinical trials by reviewing data in real time, while the Supreme Court prepares to hear a pivotal case on 'skinny labels'.
As midterm elections approach, a significant 64% of Americans express anxiety over health care costs, highlighting ongoing affordability issues despite rising concerns about gas prices.
Experts in food safety express worries about a potential brain drain at the USDA, alongside updates on health topics including autism and dementia.
Robert F. Kennedy Jr. has indicated significant changes regarding FDA oversight of peptides, and recent developments suggest he is moving forward with his plans.
A group of medical students emphasizes the importance of integrating nutrition into medical training, advocating for a shift toward preventive health education.
While modern medicine aims to improve health, it often overlooks the importance of patient comfort and emotional well-being, leading many to seek alternative options.
A new report released on Wednesday showcases achievements in addressing health disparities across U.S. states from 2022 to 2024, though experts express caution about their sustainability.
During its inaugural meeting, the federal autism committee concentrated on issues related to profound autism, following significant changes in its membership.
During a recent Congressional hearing, health system CEOs faced little accountability as committee members pointed fingers at opposing party policies for rising health care costs.
The advocacy group PrEP4All has initiated legal proceedings against the Trump administration, challenging an undisclosed agreement with Gilead that raises transparency concerns.
The FDA is embarking on a new initiative aimed at utilizing artificial intelligence to monitor clinical trials in real time, potentially reducing the duration between trial phases.
STAT is seeking input on whether to adopt 'healthcare' or 'health care' in its publications. Your opinion matters.
The FDA commissioner highlights how real-time clinical trials could change the landscape of drug development by providing regulators with immediate data insights.
David Morens, an adviser to Dr. Anthony Fauci, faces indictment for allegedly concealing emails and evading records requests, linked to inquiries about the origins of COVID-19.
The Supreme Court is set to hear arguments regarding skinny labeling, a practice that may affect the accessibility of generic medications in the market.